Inimex Pharmaceuticals
Innate Defense Regulators
Inimex Pharmaceuticals, Inc. is a clinical stage company focused on the development and commercialization of Innate Defense Regulators (IDRs), novel first in class drugs that selectively trigger the body’s innate defenses without causing...Homepage: http://www.inimexpharma.com
Total money raised: $26.5M
V5A 4T8
8540 Baxter Place
Burnaby, B.C.
CAN
Burnaby, B.C.
CAN
Phone: (604) 225-2251
Updated on Aug 24, 2009
Inimex Pharmaceuticals at CrunchBase
John R. North President & CEOInimex Pharmaceuticals at CrunchBase
Martin (Marty) McConnell CFO
Oreola Donini Senior Director
Past
June, 2008
Inimex Pharmaceuticals raised $22M in a Series B round from Canadian Medical Discoveries Fund, Astellas Venture Management, Morningside Group, Roche Venture Fund, BC Advantage Funds, Discovery Capital, BDC Venture Capital, and GrowthWorks Capital
July, 2004
Inimex Pharmaceuticals raised $4.5M in a Series A round from BDC Venture Capital, Canadian Medical Discoveries Fund, and GrowthWorks Capital
Inimex Pharmaceuticals Announces $2 Million Second Closing of Series A 
inimexpharma.com